Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Wien Klin Wochenschr ; 113 Suppl 3: 59-61, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-15503623

RESUMEN

Approximately 30 patients with familial hypomagnesemia-hypercalciuria have been reported. We describe an 8-year-old girl with cardinal findings of familial hypomagnesemia-hypercalciuria (hypomagnesemia, hypermagnesiuria, hypercalciuria, renal insufficiency, hyperuricemia, elevated serum parathormone, hyposthenuria and nephrocalcinosis), who received combination therapy consisting of magnesium salts, thiazide diuretic and potassium supplementation. At the 4-year follow-up investigation under this treatment, the patient was found to have cerebral pseudotumor (increased intracranial pressure with normal or small ventricles on neuroimaging, no evidence of an intracranial mass and normal cerebrospinal fluid composition) with papilledema and visual field defects. Thiazide therapy was terminated and the cerebral pseudotumor disappeared. The authors hypothesize that cerebral pseudotumor in this patient was related to severe hypocalcemia, as a consequence of profound hypomagnesemia induced by protracted thiazide treatment. To our knowledge, this is the first report of a child with familial hypomagnesemia-hypercalciuria who developed pseudotumor cerebri after thiazide therapy.


Asunto(s)
Calcio/orina , Deficiencia de Magnesio/genética , Nefrocalcinosis/genética , Seudotumor Cerebral/genética , Niño , Diuréticos , Quimioterapia Combinada , Femenino , Estudios de Seguimiento , Humanos , Hipocalcemia/inducido químicamente , Hipocalcemia/diagnóstico , Compuestos de Magnesio/efectos adversos , Compuestos de Magnesio/uso terapéutico , Deficiencia de Magnesio/tratamiento farmacológico , Nefrocalcinosis/diagnóstico , Nefrocalcinosis/tratamiento farmacológico , Politiazida/efectos adversos , Politiazida/uso terapéutico , Potasio/efectos adversos , Potasio/uso terapéutico , Seudotumor Cerebral/inducido químicamente , Seudotumor Cerebral/diagnóstico , Factores de Riesgo , Inhibidores de los Simportadores del Cloruro de Sodio/efectos adversos , Inhibidores de los Simportadores del Cloruro de Sodio/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA